Hao Xu, Hao Xu, Hao Xu, Hao Xu, Hao Xu, Hao Xu, . . . Weilin Wang. (2022). MLN2238 exerts its anti-tumor effects via regulating ROS/JNK/mitochondrial signaling pathways in intrahepatic cholangiocarcinoma. Frontiers Media S.A..
Chicago Style (17th ed.) CitationHao Xu, et al. MLN2238 Exerts Its Anti-tumor Effects via Regulating ROS/JNK/mitochondrial Signaling Pathways in Intrahepatic Cholangiocarcinoma. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationHao Xu, et al. MLN2238 Exerts Its Anti-tumor Effects via Regulating ROS/JNK/mitochondrial Signaling Pathways in Intrahepatic Cholangiocarcinoma. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.